Like ADC, CAR-T cells therapy needs to be very specific because of the risk of off-target that could lead to strong side effects even though expected results should be potentially higher regarding its long-term efficacy
For patients who need a dose adjustment, have an insurance prior authorization requirement, or are looking to switch formulations, the on-demand pathway is not available - they must schedule a full consultation
The Golden Era of Incretin Therapy: A Visual Summary As an Endocrinologist, keeping pace with the rapid evolution of GLP-1 Receptor Agonists (and the new twincretins) is both a challenge and a privilege
Since 1993, we've helped countless hospitals and care centers overcome their biggest supply chain challenges and build a consistent stream of high-quality medical supplies
10.3390/molecules16086732 38 JiangH.WangX.HuangL.LuoZ.SuT.DingK.et al (2011)
Prez-Miguelsanz, J., Vallecillo, N., Garrido, F., Reytor, E., Prez-Sala, D